Conferences

Last Update: 15th Jan 2018

Conference Participation

Upcoming | Past Speaker | Poster Presentations


Upcoming, confirmed:

 

Lorne Cancer 2018
February 2018
Lorne, Victoria, Australia
Invited Speaker
More info

Hunter Cell Signalling Meeting 2018
March 2018
Hunter Valley, NSW, Australia
Invited Speaker

QMB Shanghai Meeting 2018
March 2018
Shanghai, China
Invited Speaker


Past speaker:

2017

29. 9th Auckland Mechano- and Matrix Biology Symposium
November 2017
Auskland, New Zealand
Invited Speaker
“Studying the dynamic ECM landscape in cancer”

28. 8th Barossa Cell Signalling Meeting
November 2017
Barossa Valley, SA, Australia
Speaker selected from abstract
“Studying the dynamic ECM landscape in cancer”

27. Danish Cancer Society Symposium 2017 – “Metastasis as a systemic disease
October 2017
Copenhagen, Denmark
Invited Speaker
“The dynamic ECM landscape in cancer”

26. 25th Annual Silver Anniversary St Vincent’s Health Australia Symposium
September 2017
Sydney, Australia
Speaker selected from abstract
“The dynamic ECM landscape in cancer”

25. Queenstown Research Week – Molecular Biology Meeting
September 2017
Queenstown, New Zealand
Invited Speaker
“Remodelling of the ECM in cancer”

24. Sydney Catalyst 6th Post Graduate and Early Career Researcher Symposium
April 2017
Sydney, Australia
Keynote Speaker

23. British Society for Matrix Biology (BSMB) Spring Meeting – “Matrix Proteoglycans”
April 2017
Oxford, UK
Speaker selected from abstract
Visualising ECM Remodelling in Cancer: ISDoT – In Situ Decellularisation of Tissues
More info

22. Cancer Network Zurich – Cancer Biology Symposium 2017
March 2017
Zurich, Switzerland
Invited Speaker
“ECM Remodelling in Cancer: Implications for metastatic organotropism”

2016

21. Matrix Biology of Australia and New Zealand (MBSANZ)
November 2016
University of Sydney Camden Campus, Australia
Invited Speaker
“ECM Remodelling in Tumour Progression and Metastasis
More info

20. 8th Garvan Signalling Symposium 2016
Oct – Nov 2016
Sydney, Australia
Invited Speaker
“ECM Remodelling in Tumour Progression and Metastasis”
More Info

19. Metastasis Research Society (MRS) 16th Biennial meeting
Chengdu, China
August 2016
Invited Short Talk, Session Chair
“Cancer: Opening LOX to Metastasis – The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase”

18. British Society for Matrix Biology (BSMB) Autumn Meeting – “The Art of Communication – Signalling cascades in mechanotransduction
Cardiff, Wales, UK
August 2016
Young Investigator John Scott Award Plenary Lecture
Fibrosis, Cancer and the Pre-Metastatic Niche:Implications for Lysyl Oxidases in Cancer Progression and Metastasis”
More info

17. Amine Oxidase Biennial Meeting 2016
Birmingham, United Kingdom
July 2016
Invited Speaker
Lysyl oxidases in cancer progression and metastasis

16. AACR Annual Conference 2016 (#AACR16)
New Orleans, LA, United States
April 2016
Invited Speaker, Major Symposia
“ECM Remodeling at the Pre-metastatic Niche: Implications for Lysyl Oxidase in Metastasis Organotropism”
More info

2015

15. CNIO Frontiers Meeting on “Metastasis Initiation: Mechanistic Insights and Therapeutic Opportunities
Madrid, Spain
September 2015
Speaker selected from abstract
“Cancer – Opening LOX to metastasis: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase”
More info

2014

14. Metastasis Research Society (MRS) 15th Biennial Congress
Heidelberg, Germany
Young Investigator Keynote Speaker, Session Chair
“Fibrosis, Cancer and the Pre-Metastatic Niche: Implications for Lysyl Oxidase”
More info

13. British Society for Matrix Biology (BSMB): “Building the extracellular matrix: Molecules, Cells and Evolution
Bristol, United Kingdom
Speaker selected from abstract
“Pre-Metastatic bone lesions in breast cancer: Implications for Lysyl Oxidase”

12. ICCMSE 2014: “Functional diversity of LOX and LOX-like proteins
Athens, Greece
Invited Speaker
Lysyl Oxidases in Metastasis

2013

11. International Conference on Systems Biology (ICSB)
Copenhagen, Denmark
Speaker selected from abstract
“Deep proteomic analysis of the hypoxic secretome reveals lysyl oxidase as a critical mediator of pre-metastatic bone lesions in breast cancer”

10. Biotech Research & Innovation Centre 10 year Symposium on “Cancer Biology
Copenhagen, Denmark
Speaker selected from abstract
“The Hypoxic Secretome Reveals Lysyl Oxidase as a critical mediator of pre-metastatic bone lesions in breast cancer”

9. Gordon Research Conference (GRC) on “Collagen: In the Context of Matrix, Cells and Regenerative Medicine
New London, NH, United States
Invited Speaker
“Lysyl Oxidases in Cancer Progression”

8. 5th MaxQuant Summer School on Computational Mass Spectrometry Based Proteomics
Munich, Germany
Speaker Selected from Abstract
High-throughput, multi-platform modelling of cancer metastasis

7. Systems Medicine in Cancer (SMiC)
Berlin, Germany
Speaker Selected from Abstract
Network modelling to identify differences in networks between non-metastatic and metastatic tumour states

2012

6. ICTR-PHE; “Uniting physics, biology and medicine for better healthcare
Geneva, Switzerland
Invited Speaker
Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer

2011

5. Joint TuMIC-MRS Conference; “New Concepts in Cancer Metastasis
Lisbon, Portugal
Invited Speaker, AICR Lecture
The Metastatic Microenvironment: Implications for Lysyl Oxidase in Fibrosis-Enhanced Breast Cancer Metastasis
More Info

4. Cold Spring Harbor; “The Biology of Cancer: Microenvironment, Metastasis & Therapeutics
Cold Spring Harbor, New York, USA
Speaker Selected from Abstract
Fibrosis and the pre-metastatic niche: Implications for Lysyl Oxidase

2010

3. British Society for Matrix Biology (BSMB): “Inflammation Meets Matrix Biology”
Norwich, United Kingdom
Speaker Selected from Abstract
Matrix Remodelling and The Pre-Metastatic Niche: Implications for Lysyl Oxidase

2009

2. Beatson International Cancer Conference: “Microenvironment, Motility and Metastasis
Glasgow, United Kingdom
AICR Selected Short Talk
A critical role for lysyl oxidase in pre-metastatic niche formation

1. Institute of Cancer Research (ICR) Centenary Conference: “From Genes to Drugs
London, United Kingdom
Speaker selected from Abstract
Stopping the spread: Lysyl oxidase and the pre-metastatic niche


Poster Presentations

2017

29th Annual Lorne Cancer Conference
Lorne, VIC, Australia
ISDoT: In Situ Decellularisation of Tissues for high resolution imaging and proteomic analysis of native extracellular matrix

2014

British Society for Matrix Biology (BSMB): “Location, Location, Location; the matrix and the microenvironment
Bristol, United Kingdom
Biomechanical and biochemical modulation of extracellular matrix properties during colorectal cancer progression

2013

Beatson International Cancer Conference: “Targeting the Tumour Stroma
Glasgow, United Kingdom
The hypoxic secretome reveals lysyl oxidase as a critical mediator of pre-metastatic bone lesions in breast cancer

2012

Metastasis Research Society (MRS) 14th Biennial Congress
Brisbane, Australia
Microenvironmental regulation of kinase signalling dynamics as a critical mediator of tumour metastasis

Integrative Network Biology: “Network Medicine”
Helsingør, Denmark
Remodelling of the ECM as a critical mediator of tumour metastasis

British Society for Matrix Biology (BSMB): “Matrix Molecular Biology: Integrator of Tissue Function and Disease
Oxford, United Kingdom
Lysyl Oxidase mediates micro-environmental stiffness to drive colorectal cancer progression through FAK

2011

Beatson International Cancer Conference: “Cancer Models and Novel Therapies”
Glasgow, United Kingdom
Fibrosis and the pre-metastatic niche: Implications for lysyl oxidase

2010

UK Adhesion Society: “Get Connected
Manchester, United Kingdom
Matrix remodeling and the pre-metastatic niche: Implications for lysyl oxidase

MetaFight: “Unraveling Cancer Cell Invasion and Metastasis
Turin, Italy
Matrix remodeling and the pre-metastatic niche: Implications for lysyl oxidase